Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) posted a 18.13% year-on-year (YoY) increase in the first four months of fiscal year (FY) 2022/2023, according to the financial income statement filed to the Egyptian Exchange (EGX) on December 11thth.

Net profit after tax amounted to EGP 55.62 million in the four-month period ended October 31st, compared to EGP 47.08 million in the same period of FY 2021/2022.

The company’s operating revenues rose to EGP 464.415 million in the July-October period of FY 2022/2023 from EGP 380.117 million the same period a FY earlier.

Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.

 

Copyright © 2022 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).